Christopher Webb

Christopher Webb

Auto-generated profile, based on publicly available information

Christopher Webb

Broadgreen University Hospital , Liverpool, United Kingdom

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2019 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
MWMark D. Wilkie
Mark D. Wilkie
DCD Chudek
D Chudek
CWC J Webb
C J Webb
APA Panarese
A Panarese
GBG Banhegyi
G Banhegyi
Objective: This study sought to compare disease recidivism rates between canal wall up mastoidectomy and a canal wall down with obliteration technique.Methods: Patients undergoing primary cholesteatoma surgery at our institution over a five-year period (2013–2017) using the aforementioned techniques were eligible for inclusion in the study. Rates of discharge and disease recidivism were analysed using chi-square statistics.Results: A total of 104 ears (98 patients) were included. The mean follow-up period was 30 months (range, 12–52 months). A canal wall down with mastoid obliteration technique was performed in 55 cases and a canal wall up approach was performed in 49 cases. Disease recidivism rates were 7.3 per cent and 16.3 per cent in the canal wall down with mastoid obliteration and canal wall up groups respectively (p = 0.02), whilst discharge rates were similar (7.3 per cent and 10.2 per cent respectively).Conclusion: Our direct comparative data suggest that canal wall down mastoidectomy with obliteration is superior to a canal wall up technique in primary cholesteatoma surgery, providing a lower recidivism rate combined with a low post-operative ear discharge rate.

1 January 2005 in The Journal of Laryngology & Otology
Verified
Journal Article
Closed access
PDF file
HBH L Beer
H L Beer
SDS Duvvi
S Duvvi
CWC J Webb
C J Webb
STS Tandon
S Tandon
Thirty-two members of staff from the Ear, Nose and Throat Department at Warrington General Hospital were asked to estimate blood loss in commonly encountered epistaxis scenarios. Results showed that once the measured volume was above 100 ml, visual estimation became grossly inaccurate. Comparison of medical and non-medical staff showed under-estimation was more marked in the non-medical group. Comparison of doctors versus nurses showed no difference in estimation, and no difference was found between grades of staff.

9 March 2020 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
JHJacob B. Hammond
Jacob B. Hammond
CWChristopher J. Webb
Christopher J. Webb
VPVenkata S. K. K. Pulivarthi
Venkata S. K. K. Pulivarthi
DPDavid G. Pearson
David G. Pearson
KHKristi L. Harold
Kristi L. Harold
JMJames A. Madura
James A. Madura

26 April 2021 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
CWChristopher Webb
Christopher Webb
YCYu‐Hui Chang
Yu‐Hui Chang
BPBarbara A. Pockaj
Barbara A. Pockaj
RGRichard J. Gray
Richard J. Gray
CSChee‐Chee Stucky
Chee‐Chee Stucky
NWNabil Wasif
Nabil Wasif

16 August 2020 in Surgery
Verified
Journal Article
Closed access
PDF file
CWChristopher Webb
Christopher Webb
PCPatricia Cronin
Patricia Cronin
NGNikita Gupta
Nikita Gupta
JVJens Verhey
Jens Verhey
ECEsteban Calderon
Esteban Calderon
CSChee-Chee Stucky
Chee-Chee Stucky

1 May 2021 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
MZM Zammit
M Zammit
SHS Hardy
S Hardy
JHJ Harper
J Harper
APA Panarese
A Panarese
CWC Webb
C Webb
Introduction: Subglottic stenosis (SGS) is the commonest manifestation of tracheobronchial disease in granulomatosis with polyangiitis (GPA) and carries a high degree of morbidity. Management of SGS-GPA is a double-edged sword. Delayed treatment may cause respiratory compromise and infectious complications. However, aggressive surgical management may initiate a systemic inflammatory response, reactivating the vasculitic cascade and potentially lead to long-term complications including renal vasculitis and consequential end-stage renal failure. There is currently no internationally agreed management strategy for this disease. Method: This retrospective review was undertaken to analyse our unique combination of surgical dilatations and immunosuppressive-focused adjuvant management strategy between years 2011-2020. Results: Sixteen of our one hundred and nine GPA patients (14.7%) had SGS and were included in our analysis. Whilst three patients (18.8%) improved solely on medical treatment, thirteen (81.3%) required combined surgery and immunosuppression (consisting of cyclophosphamide or Rituximab regimens). Thirty-nine surgical dilatations and two tracheostomies were performed over a mean 53-month follow-up period, with a calculated mean procedure rate of one every 24.8 months (2.7 - 89 months). Conclusions: Our current management strategy affords a lower procedure rate at every 24.8 months compared to other published studies with combined procedure rate at every 14.9 months.